Bain buys 340-year-old pharma company to fast-track Japan’s drug development
Stay informed with free updates Simply sign up to the Pharmaceuticals sector myFT Digest -- delivered directly to your inbox. Bain Capital has placed a $3.3bn bet on a historic shift in Japan’s conservative drugs approval regime by buying a pharmaceutical …